Literature DB >> 32773099

SARS-CoV-2 pandemic: An overview.

Cecilia Acuti Martellucci1, Maria Elena Flacco2, Rosaria Cappadona2, Francesca Bravi3, Lorenzo Mantovani4, Lamberto Manzoli5.   

Abstract

By the end of May 2020, SARS-CoV-2 pandemic caused more than 350,000 deaths worldwide. In the first months, there have been uncertainties on almost any area: infection transmission route, virus origin and persistence in the environment, diagnostic tests, therapeutic approach, high-risk subjects, lethality, and containment policies. We provide an updated summary of the current knowledge on the pandemic, discussing the available evidence on the effectiveness of the adopted mitigation strategies.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  COVID-19; Containment policies; Diagnostic tests; Epidemiology; Mortality; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32773099     DOI: 10.1016/j.jbior.2020.100736

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  21 in total

1.  Efficiency of antiviral treatment in COVID-19.

Authors:  Nicoleta Negrut; Adriana Codrean; Ioana Hodisan; Simona Bungau; Delia Mirela Tit; Ruxandra Marin; Tapan Behl; Florin Banica; Camelia C Diaconu; Delia Carmen Nistor-Cseppento
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

Review 2.  [Risk communication in the containment of the COVID-19 pandemic: challenges and promising approaches].

Authors:  Julika Loss; Evgeniya Boklage; Susanne Jordan; Mirjam A Jenny; Heide Weishaar; Charbel El Bcheraoui
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02-09       Impact factor: 1.513

3.  Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies.

Authors:  Maimoona Zia; Shabbir Muhammad; Shamsa Bibi; Sumra Wajid Abbasi; Abdullah G Al-Sehemi; Aijaz Rasool Chaudhary; Fu Quan Bai
Journal:  Bioorg Med Chem Lett       Date:  2021-05-01       Impact factor: 2.823

4.  Severe Acute Respiratory Syndrome Coronavirus 2 Lethality Did not Change Over Time in Two Italian Provinces.

Authors:  Maria Elena Flacco; Cecilia Acuti Martellucci; Francesca Bravi; Giustino Parruti; Alfonso Mascitelli; Lorenzo Mantovani; Stefania Boccia; Lamberto Manzoli
Journal:  Open Forum Infect Dis       Date:  2020-11-12       Impact factor: 3.835

5.  COVID-19 associated myocarditis: A systematic review.

Authors:  William Haussner; Antonio P DeRosa; Danielle Haussner; Jacqueline Tran; Jane Torres-Lavoro; Jonathan Kamler; Kaushal Shah
Journal:  Am J Emerg Med       Date:  2021-10-22       Impact factor: 4.093

6.  The effectiveness of commercial household ultraviolet C germicidal devices in Thailand.

Authors:  Pasita Palakornkitti; Prinpat Pinyowiwat; Somsak Tanrattanakorn; Natta Rajatanavin; Ploysyne Rattanakaemakorn
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

Review 7.  COVID-19 in normal, diseased and transplanted liver.

Authors:  Alessandro Signorello; Ilaria Lenci; Martina Milana; Giuseppe Grassi; Leonardo Baiocchi
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

8.  Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2.

Authors:  Shafi Mahmud; Gobindo Kumar Paul; Suvro Biswas; Shamima Afrose; Mohasana Akter Mita; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Alomgir Hossain; Maria Meha Promi; Fahmida Khan Ema; Kumarappan Chidambaram; Balakumar Chandrasekaran; Ali M Alqahtani; Talha Bin Emran; Md Abu Saleh
Journal:  Front Mol Biosci       Date:  2021-05-10

9.  Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province.

Authors:  Maria Elena Flacco; Graziella Soldato; Cecilia Acuti Martellucci; Roberto Carota; Rossano Di Luzio; Antonio Caponetti; Lamberto Manzoli
Journal:  Vaccines (Basel)       Date:  2021-06-10

10.  Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2.

Authors:  Iulia Nedelcu; Raluca Jipa; Roxana Vasilescu; Cristian Băicuș; Costin-Ioan Popescu; Eliza Manea; Laura E Stoichițoiu; Larisa Pinte; Anca Damalan; Oana Simulescu; Irina Stoica; Madalina Stoica; Adriana Hristea
Journal:  Viruses       Date:  2021-06-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.